Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3028% below fair value
$3.31+0.24 (+7.82%)
Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –
Nephros gross margin
Gross margin is gross profit as a percentage of revenue.
Nephros's gross margin for the twelve months ending Sep 30, 2026 was 60.5%. For fiscal 2025 it was 61.9%, against 61.6% the year before. The highest annual figure on record is 68.6% in fiscal 2014.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61.9% | +0.3 |
| FY2024 | Dec 31, 2024 | 61.6% | +2.6 |
| FY2023 | Dec 31, 2023 | 59.0% | +11.6 |
| FY2022 | Dec 31, 2022 | 47.4% | −7.7 |
| FY2021 | Dec 31, 2021 | 55.1% | −2.3 |
| FY2020 | Dec 31, 2020 | 57.4% | −1.5 |
| FY2019 | Dec 31, 2019 | 58.9% | +2.6 |
| FY2018 | Dec 31, 2018 | 56.3% | −3.9 |
| FY2017 | Dec 31, 2017 | 60.2% | +4.4 |
| FY2016 | Dec 31, 2016 | 55.8% | +1.2 |
| FY2015 | Dec 31, 2015 | 54.5% | −14.1 |
| FY2014 | Dec 31, 2014 | 68.6% | +20.2 |
| FY2013 | Dec 31, 2013 | 48.4% | −10.8 |
| FY2012 | Dec 31, 2012 | 59.2% | +20.0 |
| FY2011 | Dec 31, 2011 | 39.2% | +1.0 |
| FY2010 | Dec 31, 2010 | 38.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 58.4% | −2.7 |
| Q2 FY2026 | Jun 30, 2026 | 66.9% | +3.7 |
| Q1 FY2026 | Mar 31, 2026 | 57.4% | −7.2 |
| Q4 FY2025 | Dec 31, 2025 | 58.4% | −5.6 |
| Q3 FY2025 | Sep 30, 2025 | 61.2% | +0.1 |
| Q2 FY2025 | Jun 30, 2025 | 63.2% | +4.5 |
| Q1 FY2025 | Mar 31, 2025 | 64.7% | +2.6 |
| Q4 FY2024 | Dec 31, 2024 | 64.0% | +1.8 |
| Q3 FY2024 | Sep 30, 2024 | 61.1% | +2.5 |
| Q2 FY2024 | Jun 30, 2024 | 58.8% | +0.1 |
| Q1 FY2024 | Mar 31, 2024 | 62.1% | +5.0 |
| Q4 FY2023 | Dec 31, 2023 | 62.1% | +3.1 |
| Q3 FY2023 | Sep 30, 2023 | 58.6% | +27.0 |
| Q2 FY2023 | Jun 30, 2023 | 58.6% | +9.7 |
| Q1 FY2023 | Mar 31, 2023 | 57.1% | +8.3 |
| Q4 FY2022 | Dec 31, 2022 | 59.0% | +4.8 |
| Q3 FY2022 | Sep 30, 2022 | 31.6% | −21.1 |
| Q2 FY2022 | Jun 30, 2022 | 48.9% | −7.3 |
| Q1 FY2022 | Mar 31, 2022 | 48.8% | −9.2 |
| Q4 FY2021 | Dec 31, 2021 | 54.2% | −1.6 |
| Q3 FY2021 | Sep 30, 2021 | 52.8% | −5.0 |
| Q2 FY2021 | Jun 30, 2021 | 56.3% | −0.5 |
| Q1 FY2021 | Mar 31, 2021 | 58.0% | −1.0 |
| Q4 FY2020 | Dec 31, 2020 | 55.8% | −4.3 |
| Q3 FY2020 | Sep 30, 2020 | 57.8% | −1.0 |
| Q2 FY2020 | Jun 30, 2020 | 56.8% | −2.4 |
| Q1 FY2020 | Mar 31, 2020 | 59.0% | +2.5 |
| Q4 FY2019 | Dec 31, 2019 | 60.1% | +0.9 |
| Q3 FY2019 | Sep 30, 2019 | 58.8% | +3.6 |
| Q2 FY2019 | Jun 30, 2019 | 59.2% | −1.6 |
| Q1 FY2019 | Mar 31, 2019 | 56.4% | +9.0 |
| Q4 FY2018 | Dec 31, 2018 | 59.2% | −1.4 |
| Q3 FY2018 | Sep 30, 2018 | 55.2% | −2.9 |
| Q2 FY2018 | Jun 30, 2018 | 60.8% | +0.6 |
| Q1 FY2018 | Mar 31, 2018 | 47.4% | −14.6 |
| Q4 FY2017 | Dec 31, 2017 | 60.6% | +8.8 |
| Q3 FY2017 | Sep 30, 2017 | 58.1% | – |
| Q2 FY2017 | Jun 30, 2017 | 60.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 62.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 51.8% | – |
See a number that looks wrong?